Late last year, Aspen, the continent’s biggest pharmaceutical company was negotiating a deal to make a Covid-19 vaccine under license from Johnson & Johnson. As the omicron variant was spreading through South Africa late last year, the continent’s biggest pharmaceutical company was negotiating a deal to make a Covid-19 vaccine under license from Johnson & Johnson. The dearth of business is jarring for Aspen executives and those of other companies setting up vaccine facilities in Africa. Financial FailureAspen’s vaccine, which uses the J&J substance but has the brand name Aspenovax, became the first Covid-19 inoculation produced in Africa for Africans. "What will become of the about 10 countries that have engaged in vaccine manufacturing in Africa?"

Source: News 24 May 19, 2022 07:29 UTC